Tag: blockbuster drugs
Blockbuster Patent Expirations: What to Expect in 2025 and Beyond
Pharmaceutical patent expirations from 2025-2030 will see $250 billion in drug sales face generic competition. Key drugs like Keytruda and Entresto will drop in price, saving patients billions. Companies are racing to develop new therapies and prepare for market shifts. Patients can expect cheaper medications, but supply chain challenges may arise. This timeline reshapes healthcare economics and drug access globally.
DetailRelated Posts
